FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:FAF1-SKI

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: FAF1-SKI
FusionPDB ID: 28249
FusionGDB2.0 ID: 28249
HgeneTgene
Gene symbol

FAF1

SKI

Gene ID

11124

6497

Gene nameFas associated factor 1SKI proto-oncogene
SynonymsCGI-03|HFAF1s|UBXD12|UBXN3A|hFAF1SGS|SKV
Cytomap

1p32.3

1p36.33-p36.32

Type of geneprotein-codingprotein-coding
DescriptionFAS-associated factor 1Fas (TNFRSF6) associated factor 1TNFRSF6-associated factor 1UBX domain protein 3AUBX domain-containing protein 12UBX domain-containing protein 3Aski oncogeneproto-oncogene c-Skiski oncoproteinv-ski avian sarcoma viral oncogene homolog
Modification date2020031320200329
UniProtAcc

Q9UNN5

Main function of 5'-partner protein: FUNCTION: Ubiquitin-binding protein (PubMed:19722279). Required for the progression of DNA replication forks by targeting DNA replication licensing factor CDT1 for degradation (PubMed:26842564). Potentiates but cannot initiate FAS-induced apoptosis (By similarity). {ECO:0000250|UniProtKB:P54731, ECO:0000269|PubMed:19722279, ECO:0000269|PubMed:26842564}.

SKIDA1,C10orf140

Main function of 5'-partner protein: 908
Ensembl transtripts involved in fusion geneENST idsENST00000371778, ENST00000396153, 
ENST00000472808, ENST00000545823, 
ENST00000478223, ENST00000378536, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score23 X 21 X 9=434717 X 5 X 6=510
# samples 3117
** MAII scorelog2(31/4347*10)=-3.80967997500385
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(17/510*10)=-1.58496250072116
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: FAF1 [Title/Abstract] AND SKI [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: FAF1 [Title/Abstract] AND SKI [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)FAF1(51425439)-SKI(2234417), # samples:2
SKI(2161174)-FAF1(51267349), # samples:3
Anticipated loss of major functional domain due to fusion event.FAF1-SKI seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
FAF1-SKI seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
SKI-FAF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SKI-FAF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
FAF1-SKI seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
FAF1-SKI seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF.
FAF1-SKI seems lost the major protein functional domain in Tgene partner, which is a transcription factor due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneFAF1

GO:0010942

positive regulation of cell death

15596450

TgeneSKI

GO:0000122

negative regulation of transcription by RNA polymerase II

17469184

TgeneSKI

GO:0008285

negative regulation of cell proliferation

11430826

TgeneSKI

GO:0014902

myotube differentiation

19008232

TgeneSKI

GO:0030512

negative regulation of transforming growth factor beta receptor signaling pathway

17469184

TgeneSKI

GO:0030514

negative regulation of BMP signaling pathway

14699069

TgeneSKI

GO:0032926

negative regulation of activin receptor signaling pathway

14699069

TgeneSKI

GO:0043388

positive regulation of DNA binding

15107821

TgeneSKI

GO:0045668

negative regulation of osteoblast differentiation

14699069

TgeneSKI

GO:0060395

SMAD protein signal transduction

12874272



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:51425439/chr1:2234417)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across FAF1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across SKI (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000396153FAF1chr151425439-ENST00000378536SKIchr12234417+50694971401714524
ENST00000396153FAF1chr151425438-ENST00000378536SKIchr12234416+50694971401714524

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000396153ENST00000378536FAF1chr151425439-SKIchr12234417+0.0039755770.99602437
ENST00000396153ENST00000378536FAF1chr151425438-SKIchr12234416+0.0039755770.99602437

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for FAF1-SKI

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
FAF1chr151425438SKIchr1223441649748GAPEGYRVHERLALPALPRPLARRPA
FAF1chr151425439SKIchr1223441749748GAPEGYRVHERLALPALPRPLARRPA

Top

Potential FusionNeoAntigen Information of FAF1-SKI in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
FAF1-SKI_51425438_2234416.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
FAF1-SKIchr151425438chr12234416497HLA-B39:24ERLALPAL0.99990.6683917
FAF1-SKIchr151425438chr12234416497HLA-B14:02ERLALPAL0.99990.8956917
FAF1-SKIchr151425438chr12234416497HLA-B14:01ERLALPAL0.99990.8956917
FAF1-SKIchr151425438chr12234416497HLA-B39:01ERLALPAL0.99980.9094917
FAF1-SKIchr151425438chr12234416497HLA-B15:37ERLALPAL0.99620.581917
FAF1-SKIchr151425438chr12234416497HLA-B50:01HERLALPA0.94760.7632816
FAF1-SKIchr151425438chr12234416497HLA-B27:02YRVHERLAL0.99980.6222514
FAF1-SKIchr151425438chr12234416497HLA-B27:07YRVHERLAL0.99980.5205514
FAF1-SKIchr151425438chr12234416497HLA-B27:04YRVHERLAL0.99980.7559514
FAF1-SKIchr151425438chr12234416497HLA-B27:05YRVHERLAL0.99980.8585514
FAF1-SKIchr151425438chr12234416497HLA-B39:01YRVHERLAL0.99850.8085514
FAF1-SKIchr151425438chr12234416497HLA-B39:06YRVHERLAL0.99810.7574514
FAF1-SKIchr151425438chr12234416497HLA-B14:01YRVHERLAL0.99760.5991514
FAF1-SKIchr151425438chr12234416497HLA-B14:02YRVHERLAL0.99760.5991514
FAF1-SKIchr151425438chr12234416497HLA-A74:11RLALPALPR0.99670.92691019
FAF1-SKIchr151425438chr12234416497HLA-A74:03RLALPALPR0.99670.92691019
FAF1-SKIchr151425438chr12234416497HLA-A74:09RLALPALPR0.99670.92691019
FAF1-SKIchr151425438chr12234416497HLA-A03:25RLALPALPR0.99630.62421019
FAF1-SKIchr151425438chr12234416497HLA-B48:01HERLALPAL0.99630.6346817
FAF1-SKIchr151425438chr12234416497HLA-A03:12RLALPALPR0.99620.65221019
FAF1-SKIchr151425438chr12234416497HLA-B14:01HERLALPAL0.99360.8641817
FAF1-SKIchr151425438chr12234416497HLA-B14:02HERLALPAL0.99360.8641817
FAF1-SKIchr151425438chr12234416497HLA-A31:06RLALPALPR0.99350.8341019
FAF1-SKIchr151425438chr12234416497HLA-A11:04RLALPALPR0.99330.58551019
FAF1-SKIchr151425438chr12234416497HLA-B39:06VHERLALPA0.99240.9351716
FAF1-SKIchr151425438chr12234416497HLA-B38:02YRVHERLAL0.9910.9174514
FAF1-SKIchr151425438chr12234416497HLA-B38:01YRVHERLAL0.98890.9183514
FAF1-SKIchr151425438chr12234416497HLA-B15:10YRVHERLAL0.96560.5047514
FAF1-SKIchr151425438chr12234416497HLA-A31:02RLALPALPR0.96420.91141019
FAF1-SKIchr151425438chr12234416497HLA-B15:18YRVHERLAL0.83960.6743514
FAF1-SKIchr151425438chr12234416497HLA-B18:01HERLALPAL0.83910.8381817
FAF1-SKIchr151425438chr12234416497HLA-B39:13HERLALPAL0.83130.9228817
FAF1-SKIchr151425438chr12234416497HLA-B47:01HERLALPAL0.75510.6114817
FAF1-SKIchr151425438chr12234416497HLA-B41:01HERLALPAL0.59240.9357817
FAF1-SKIchr151425438chr12234416497HLA-B15:37HERLALPAL0.47090.6051817
FAF1-SKIchr151425438chr12234416497HLA-B50:01HERLALPAL0.35120.9296817
FAF1-SKIchr151425438chr12234416497HLA-B38:01VHERLALPAL0.98920.9688717
FAF1-SKIchr151425438chr12234416497HLA-B55:01ALPALPRPLA0.70740.7631222
FAF1-SKIchr151425438chr12234416497HLA-B56:01ALPALPRPLA0.6210.85711222
FAF1-SKIchr151425438chr12234416497HLA-B56:01LALPALPRPLA0.98590.77771122
FAF1-SKIchr151425438chr12234416497HLA-A74:11ALPALPRPLAR0.98380.93571223
FAF1-SKIchr151425438chr12234416497HLA-A74:09ALPALPRPLAR0.98380.93571223
FAF1-SKIchr151425438chr12234416497HLA-A74:03ALPALPRPLAR0.98380.93571223
FAF1-SKIchr151425438chr12234416497HLA-A31:02ALPALPRPLAR0.97980.93951223
FAF1-SKIchr151425438chr12234416497HLA-B55:01LALPALPRPLA0.97810.62261122
FAF1-SKIchr151425438chr12234416497HLA-A31:06ALPALPRPLAR0.97460.84751223
FAF1-SKIchr151425438chr12234416497HLA-B40:06HERLALPA0.99990.8495816
FAF1-SKIchr151425438chr12234416497HLA-B39:12ERLALPAL0.99980.9129917
FAF1-SKIchr151425438chr12234416497HLA-B14:03ERLALPAL0.93470.9341917
FAF1-SKIchr151425438chr12234416497HLA-B27:14YRVHERLAL0.99980.8025514
FAF1-SKIchr151425438chr12234416497HLA-C07:95YRVHERLAL0.99930.5933514
FAF1-SKIchr151425438chr12234416497HLA-C07:05YRVHERLAL0.99910.9273514
FAF1-SKIchr151425438chr12234416497HLA-C07:13YRVHERLAL0.99890.8841514
FAF1-SKIchr151425438chr12234416497HLA-C07:29YRVHERLAL0.99830.8694514
FAF1-SKIchr151425438chr12234416497HLA-B40:06HERLALPAL0.99830.8107817
FAF1-SKIchr151425438chr12234416497HLA-C07:27YRVHERLAL0.99820.9059514
FAF1-SKIchr151425438chr12234416497HLA-B39:12YRVHERLAL0.99810.8138514
FAF1-SKIchr151425438chr12234416497HLA-B48:03HERLALPAL0.99660.5357817
FAF1-SKIchr151425438chr12234416497HLA-A03:01RLALPALPR0.99630.62421019
FAF1-SKIchr151425438chr12234416497HLA-A31:01RLALPALPR0.99580.90741019
FAF1-SKIchr151425438chr12234416497HLA-B73:01ERLALPALP0.99290.9583918
FAF1-SKIchr151425438chr12234416497HLA-C07:46YRVHERLAL0.99230.8365514
FAF1-SKIchr151425438chr12234416497HLA-B39:05YRVHERLAL0.99090.7879514
FAF1-SKIchr151425438chr12234416497HLA-B73:01YRVHERLAL0.98810.6594514
FAF1-SKIchr151425438chr12234416497HLA-C07:19YRVHERLAL0.98510.6677514
FAF1-SKIchr151425438chr12234416497HLA-C07:67YRVHERLAL0.98390.909514
FAF1-SKIchr151425438chr12234416497HLA-C07:80YRVHERLAL0.98390.909514
FAF1-SKIchr151425438chr12234416497HLA-B44:10HERLALPAL0.9820.7551817
FAF1-SKIchr151425438chr12234416497HLA-B27:03YRVHERLAL0.98020.88514
FAF1-SKIchr151425438chr12234416497HLA-C07:10YRVHERLAL0.97510.949514
FAF1-SKIchr151425438chr12234416497HLA-A02:07ALPALPRPL0.93210.90861221
FAF1-SKIchr151425438chr12234416497HLA-B14:03YRVHERLAL0.86710.661514
FAF1-SKIchr151425438chr12234416497HLA-B44:09HERLALPAL0.81830.5932817
FAF1-SKIchr151425438chr12234416497HLA-B39:08HERLALPAL0.76050.8973817
FAF1-SKIchr151425438chr12234416497HLA-B42:02HERLALPAL0.68210.696817
FAF1-SKIchr151425438chr12234416497HLA-C01:17ALPALPRPL0.4190.98671221
FAF1-SKIchr151425438chr12234416497HLA-C01:30ALPALPRPL0.40110.9841221
FAF1-SKIchr151425438chr12234416497HLA-C12:16YRVHERLAL0.37670.928514
FAF1-SKIchr151425438chr12234416497HLA-B39:05VHERLALPAL0.98480.8602717
FAF1-SKIchr151425438chr12234416497HLA-B54:01ALPALPRPLA0.85530.96131222
FAF1-SKIchr151425438chr12234416497HLA-B54:01LALPALPRPLA0.99790.94771122
FAF1-SKIchr151425438chr12234416497HLA-A31:01ALPALPRPLAR0.98620.92521223
FAF1-SKIchr151425438chr12234416497HLA-B39:31ERLALPAL0.99980.9116917
FAF1-SKIchr151425438chr12234416497HLA-B50:04HERLALPA0.94760.7632816
FAF1-SKIchr151425438chr12234416497HLA-B50:05HERLALPA0.94760.7632816
FAF1-SKIchr151425438chr12234416497HLA-B27:06YRVHERLAL0.99980.7287514
FAF1-SKIchr151425438chr12234416497HLA-B27:08YRVHERLAL0.99980.7635514
FAF1-SKIchr151425438chr12234416497HLA-B27:09YRVHERLAL0.99980.8277514
FAF1-SKIchr151425438chr12234416497HLA-B27:10YRVHERLAL0.99980.8739514
FAF1-SKIchr151425438chr12234416497HLA-C07:01YRVHERLAL0.99940.5652514
FAF1-SKIchr151425438chr12234416497HLA-B39:31YRVHERLAL0.99820.8082514
FAF1-SKIchr151425438chr12234416497HLA-B40:04HERLALPAL0.99780.9271817
FAF1-SKIchr151425438chr12234416497HLA-C07:17YRVHERLAL0.99780.9208514
FAF1-SKIchr151425438chr12234416497HLA-A74:01RLALPALPR0.99670.92691019
FAF1-SKIchr151425438chr12234416497HLA-C06:08YRVHERLAL0.99660.9828514
FAF1-SKIchr151425438chr12234416497HLA-B40:12HERLALPAL0.99660.5357817
FAF1-SKIchr151425438chr12234416497HLA-A03:02RLALPALPR0.99180.55961019
FAF1-SKIchr151425438chr12234416497HLA-B38:05YRVHERLAL0.98890.9183514
FAF1-SKIchr151425438chr12234416497HLA-C07:02YRVHERLAL0.98390.909514
FAF1-SKIchr151425438chr12234416497HLA-C07:04YRVHERLAL0.95040.8673514
FAF1-SKIchr151425438chr12234416497HLA-C07:22YRVHERLAL0.93290.5663514
FAF1-SKIchr151425438chr12234416497HLA-B18:04HERLALPAL0.88260.8388817
FAF1-SKIchr151425438chr12234416497HLA-B39:31HERLALPAL0.86840.9049817
FAF1-SKIchr151425438chr12234416497HLA-B39:02HERLALPAL0.86440.922817
FAF1-SKIchr151425438chr12234416497HLA-B15:09YRVHERLAL0.86170.57514
FAF1-SKIchr151425438chr12234416497HLA-B18:07HERLALPAL0.85950.7804817
FAF1-SKIchr151425438chr12234416497HLA-B18:05HERLALPAL0.83910.8381817
FAF1-SKIchr151425438chr12234416497HLA-B18:06HERLALPAL0.82750.8623817
FAF1-SKIchr151425438chr12234416497HLA-B18:08HERLALPAL0.81930.8839817
FAF1-SKIchr151425438chr12234416497HLA-B18:03HERLALPAL0.81630.818817
FAF1-SKIchr151425438chr12234416497HLA-C03:67YRVHERLAL0.80.9568514
FAF1-SKIchr151425438chr12234416497HLA-B41:03HERLALPAL0.79790.7513817
FAF1-SKIchr151425438chr12234416497HLA-B39:11YRVHERLAL0.79020.5172514
FAF1-SKIchr151425438chr12234416497HLA-B18:11HERLALPAL0.77990.8309817
FAF1-SKIchr151425438chr12234416497HLA-C06:06YRVHERLAL0.550.9781514
FAF1-SKIchr151425438chr12234416497HLA-C06:17YRVHERLAL0.54150.9835514
FAF1-SKIchr151425438chr12234416497HLA-C06:02YRVHERLAL0.54150.9835514
FAF1-SKIchr151425438chr12234416497HLA-B48:02HERLALPAL0.48550.8544817
FAF1-SKIchr151425438chr12234416497HLA-B15:68HERLALPAL0.40150.6856817
FAF1-SKIchr151425438chr12234416497HLA-B15:54HERLALPAL0.35920.807817
FAF1-SKIchr151425438chr12234416497HLA-B50:04HERLALPAL0.35120.9296817
FAF1-SKIchr151425438chr12234416497HLA-B50:05HERLALPAL0.35120.9296817
FAF1-SKIchr151425438chr12234416497HLA-C01:02ALPALPRPL0.29560.98621221
FAF1-SKIchr151425438chr12234416497HLA-B15:53HERLALPAL0.20420.8193817
FAF1-SKIchr151425438chr12234416497HLA-C01:03ALPALPRPL0.14740.98431221
FAF1-SKIchr151425438chr12234416497HLA-B38:05VHERLALPAL0.98920.9688717
FAF1-SKIchr151425438chr12234416497HLA-B27:06GYRVHERLAL0.98190.7001414
FAF1-SKIchr151425438chr12234416497HLA-B27:08GYRVHERLAL0.97130.5967414
FAF1-SKIchr151425438chr12234416497HLA-B39:11VHERLALPAL0.89630.808717
FAF1-SKIchr151425438chr12234416497HLA-B55:02ALPALPRPLA0.6830.90121222
FAF1-SKIchr151425438chr12234416497HLA-A74:01ALPALPRPLAR0.98380.93571223
FAF1-SKIchr151425438chr12234416497HLA-B55:02LALPALPRPLA0.98060.8721122

Top

Potential FusionNeoAntigen Information of FAF1-SKI in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
FAF1-SKI_51425438_2234416.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
FAF1-SKIchr151425438chr12234416497DRB1-0837APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1111APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1111PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1111GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1114APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1114PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1114GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1120APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1120PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1120GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1145APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1145PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1164APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1164PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1168APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1168PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1168GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1169APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1169PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1172APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1172PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1173APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1182APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1182PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1182GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1186APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1186PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1186GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1302APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1302PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1302GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-13100APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-13101APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1310APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1316APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1316PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1316GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1323APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1323PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1323GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1329APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1329PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1329GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1331APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1331PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1331GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1331EGYRVHERLALPALP318
FAF1-SKIchr151425438chr12234416497DRB1-1334APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1334PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1334GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1336APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1336PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1336GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1338APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1338PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1338GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1339APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1339PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1339GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1341APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1341PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1341GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1346APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1363APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1363PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1363GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1365APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1365PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1365GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1373APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1373PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1373GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1374APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1374PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1374GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1386APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1396APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1396PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1396GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1397APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1397PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1397GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1399APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1399PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1399GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1403APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1407APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1407PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1407GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1414APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1414PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1414GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1424APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1424PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1424GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1436APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1436PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1436GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1440APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1442APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1442PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1442GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1444APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1444PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1444GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1463APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1463PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1467APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1467PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1468APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1468PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1468GAPEGYRVHERLALP015
FAF1-SKIchr151425438chr12234416497DRB1-1477APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1485APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1493APEGYRVHERLALPA116
FAF1-SKIchr151425438chr12234416497DRB1-1493PEGYRVHERLALPAL217
FAF1-SKIchr151425438chr12234416497DRB1-1498APEGYRVHERLALPA116

Top

Fusion breakpoint peptide structures of FAF1-SKI

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
8302RVHERLALPALPRPFAF1SKIchr151425438chr12234416497

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of FAF1-SKI

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN8302RVHERLALPALPRP-7.15543-7.26883
HLA-B14:023BVN8302RVHERLALPALPRP-4.77435-5.80965
HLA-B52:013W398302RVHERLALPALPRP-6.80875-6.92215
HLA-B52:013W398302RVHERLALPALPRP-4.20386-5.23916
HLA-A11:014UQ28302RVHERLALPALPRP-7.5194-8.5547
HLA-A11:014UQ28302RVHERLALPALPRP-6.9601-7.0735
HLA-A24:025HGA8302RVHERLALPALPRP-7.52403-7.63743
HLA-A24:025HGA8302RVHERLALPALPRP-5.82433-6.85963
HLA-B27:056PYJ8302RVHERLALPALPRP-3.28285-4.31815
HLA-B44:053DX88302RVHERLALPALPRP-5.91172-6.94702
HLA-B44:053DX88302RVHERLALPALPRP-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of FAF1-SKI

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
FAF1-SKIchr151425438chr122344161019RLALPALPRGATTTTCAGGTCTCCTCTGAGCCTCCG
FAF1-SKIchr151425438chr122344161122LALPALPRPLATTTCAGGTCTCCTCTGAGCCTCCGGCCTCCATA
FAF1-SKIchr151425438chr122344161221ALPALPRPLCAGGTCTCCTCTGAGCCTCCGGCCTCC
FAF1-SKIchr151425438chr122344161222ALPALPRPLACAGGTCTCCTCTGAGCCTCCGGCCTCCATA
FAF1-SKIchr151425438chr122344161223ALPALPRPLARCAGGTCTCCTCTGAGCCTCCGGCCTCCATAAGA
FAF1-SKIchr151425438chr12234416414GYRVHERLALCGGGAGATGATCCTGGCGGATTTTCAGGTC
FAF1-SKIchr151425438chr12234416514YRVHERLALGAGATGATCCTGGCGGATTTTCAGGTC
FAF1-SKIchr151425438chr12234416716VHERLALPAATCCTGGCGGATTTTCAGGTCTCCTCT
FAF1-SKIchr151425438chr12234416717VHERLALPALATCCTGGCGGATTTTCAGGTCTCCTCTGAG
FAF1-SKIchr151425438chr12234416816HERLALPACTGGCGGATTTTCAGGTCTCCTCT
FAF1-SKIchr151425438chr12234416817HERLALPALCTGGCGGATTTTCAGGTCTCCTCTGAG
FAF1-SKIchr151425438chr12234416917ERLALPALGCGGATTTTCAGGTCTCCTCTGAG
FAF1-SKIchr151425438chr12234416918ERLALPALPGCGGATTTTCAGGTCTCCTCTGAGCCT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
FAF1-SKIchr151425438chr12234416015GAPEGYRVHERLALPTCCAACATGGACCGGGAGATGATCCTGGCGGATTTTCAGGTCTCC
FAF1-SKIchr151425438chr12234416116APEGYRVHERLALPAAACATGGACCGGGAGATGATCCTGGCGGATTTTCAGGTCTCCTCT
FAF1-SKIchr151425438chr12234416217PEGYRVHERLALPALATGGACCGGGAGATGATCCTGGCGGATTTTCAGGTCTCCTCTGAG
FAF1-SKIchr151425438chr12234416318EGYRVHERLALPALPGACCGGGAGATGATCCTGGCGGATTTTCAGGTCTCCTCTGAGCCT

Top

Information of the samples that have these potential fusion neoantigens of FAF1-SKI

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADFAF1-SKIchr151425438ENST00000396153chr12234416ENST00000378536TCGA-D7-6822

Top

Potential target of CAR-T therapy development for FAF1-SKI

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to FAF1-SKI

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to FAF1-SKI

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource